

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA unwinding involved in DNA replication (GO:0006268) | 5.16176694 |
| 2 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.94253945 |
| 3 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.79415951 |
| 4 | DNA strand elongation (GO:0022616) | 4.72663879 |
| 5 | telomere maintenance via recombination (GO:0000722) | 4.48676507 |
| 6 | mitotic recombination (GO:0006312) | 4.39983722 |
| 7 | DNA replication initiation (GO:0006270) | 4.23608943 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 4.12526192 |
| 9 | ribosomal small subunit assembly (GO:0000028) | 4.10425270 |
| 10 | negative regulation of phagocytosis (GO:0050765) | 4.08696888 |
| 11 | protein localization to kinetochore (GO:0034501) | 4.03217283 |
| 12 | negative thymic T cell selection (GO:0045060) | 3.96626025 |
| 13 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 3.94032393 |
| 14 | negative T cell selection (GO:0043383) | 3.92654222 |
| 15 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.91265134 |
| 16 | negative regulation of cell killing (GO:0031342) | 3.88872542 |
| 17 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.88872542 |
| 18 | protein localization to chromosome, centromeric region (GO:0071459) | 3.61339032 |
| 19 | DNA replication checkpoint (GO:0000076) | 3.59041714 |
| 20 | telomere maintenance via telomere lengthening (GO:0010833) | 3.58873954 |
| 21 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 3.58437128 |
| 22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.57911308 |
| 23 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.57911308 |
| 24 | positive regulation by symbiont of host defense response (GO:0052509) | 3.55305528 |
| 25 | modulation by symbiont of host defense response (GO:0052031) | 3.55305528 |
| 26 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.55305528 |
| 27 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.55305528 |
| 28 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.55305528 |
| 29 | modulation by symbiont of host immune response (GO:0052553) | 3.55305528 |
| 30 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.48855677 |
| 31 | detection of other organism (GO:0098543) | 3.48640716 |
| 32 | response to type I interferon (GO:0034340) | 3.47086579 |
| 33 | positive regulation of granulocyte differentiation (GO:0030854) | 3.46722631 |
| 34 | kinetochore organization (GO:0051383) | 3.42852349 |
| 35 | type I interferon signaling pathway (GO:0060337) | 3.41020958 |
| 36 | cellular response to type I interferon (GO:0071357) | 3.41020958 |
| 37 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.40512548 |
| 38 | detection of bacterium (GO:0016045) | 3.40159894 |
| 39 | T cell migration (GO:0072678) | 3.40087301 |
| 40 | positive thymic T cell selection (GO:0045059) | 3.37325727 |
| 41 | mitotic chromosome condensation (GO:0007076) | 3.36581945 |
| 42 | mitotic sister chromatid cohesion (GO:0007064) | 3.35837884 |
| 43 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.35396085 |
| 44 | translesion synthesis (GO:0019985) | 3.29454808 |
| 45 | response to interleukin-15 (GO:0070672) | 3.26010057 |
| 46 | CENP-A containing nucleosome assembly (GO:0034080) | 3.23633565 |
| 47 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.21559108 |
| 48 | positive regulation of interferon-alpha production (GO:0032727) | 3.20397742 |
| 49 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.19748328 |
| 50 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.18552457 |
| 51 | macrophage activation involved in immune response (GO:0002281) | 3.18507946 |
| 52 | response to peptidoglycan (GO:0032494) | 3.17775791 |
| 53 | attachment of spindle microtubules to kinetochore (GO:0008608) | 3.17172699 |
| 54 | regulation of DNA endoreduplication (GO:0032875) | 3.15725715 |
| 55 | nuclear pore complex assembly (GO:0051292) | 3.12872483 |
| 56 | chromatin remodeling at centromere (GO:0031055) | 3.11300541 |
| 57 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.10536411 |
| 58 | T cell selection (GO:0045058) | 3.09952776 |
| 59 | DNA topological change (GO:0006265) | 3.09456350 |
| 60 | meiotic chromosome segregation (GO:0045132) | 3.09160840 |
| 61 | telomere maintenance (GO:0000723) | 3.08226619 |
| 62 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.07635800 |
| 63 | regulation of interferon-alpha production (GO:0032647) | 3.05916669 |
| 64 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.05849799 |
| 65 | positive T cell selection (GO:0043368) | 3.05424916 |
| 66 | negative regulation of interleukin-12 production (GO:0032695) | 3.05039904 |
| 67 | positive regulation of B cell differentiation (GO:0045579) | 3.04808085 |
| 68 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.04604313 |
| 69 | telomere organization (GO:0032200) | 3.04510728 |
| 70 | B cell receptor signaling pathway (GO:0050853) | 3.02823486 |
| 71 | viral transcription (GO:0019083) | 3.02073283 |
| 72 | IMP biosynthetic process (GO:0006188) | 3.01343912 |
| 73 | DNA geometric change (GO:0032392) | 3.00176400 |
| 74 | DNA duplex unwinding (GO:0032508) | 3.00027147 |
| 75 | leukocyte aggregation (GO:0070486) | 2.98719181 |
| 76 | sister chromatid segregation (GO:0000819) | 2.98216084 |
| 77 | negative regulation of T cell mediated immunity (GO:0002710) | 2.96480236 |
| 78 | DNA replication-independent nucleosome organization (GO:0034724) | 2.95867456 |
| 79 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.95867456 |
| 80 | neutrophil activation involved in immune response (GO:0002283) | 2.94519339 |
| 81 | dosage compensation (GO:0007549) | 2.94480562 |
| 82 | translational termination (GO:0006415) | 2.94101621 |
| 83 | thymic T cell selection (GO:0045061) | 2.93616522 |
| 84 | detection of external biotic stimulus (GO:0098581) | 2.93316624 |
| 85 | cellular response to zinc ion (GO:0071294) | 2.91108041 |
| 86 | mitotic nuclear envelope disassembly (GO:0007077) | 2.90731114 |
| 87 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.90072025 |
| 88 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.88833847 |
| 89 | IMP metabolic process (GO:0046040) | 2.87871399 |
| 90 | cellular response to interleukin-15 (GO:0071350) | 2.87250124 |
| 91 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.84087873 |
| 92 | nuclear pore organization (GO:0006999) | 2.84061912 |
| 93 | immunoglobulin mediated immune response (GO:0016064) | 2.83247259 |
| 94 | mitotic sister chromatid segregation (GO:0000070) | 2.82780336 |
| 95 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.82575117 |
| 96 | histone-serine phosphorylation (GO:0035404) | 2.82009394 |
| 97 | regulation of B cell differentiation (GO:0045577) | 2.79539086 |
| 98 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.79286525 |
| 99 | defense response to protozoan (GO:0042832) | 2.77893633 |
| 100 | germinal center formation (GO:0002467) | 2.77798281 |
| 101 | detection of molecule of bacterial origin (GO:0032490) | 2.75385882 |
| 102 | definitive hemopoiesis (GO:0060216) | 2.75060864 |
| 103 | postreplication repair (GO:0006301) | 2.74396330 |
| 104 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.74340464 |
| 105 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.71292673 |
| 106 | myeloid cell activation involved in immune response (GO:0002275) | 2.70371169 |
| 107 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.70325385 |
| 108 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.70318085 |
| 109 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.70318085 |
| 110 | response to interferon-alpha (GO:0035455) | 2.70163049 |
| 111 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.69773744 |
| 112 | B cell mediated immunity (GO:0019724) | 2.69513881 |
| 113 | detection of biotic stimulus (GO:0009595) | 2.69190953 |
| 114 | respiratory burst (GO:0045730) | 2.69148282 |
| 115 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.69031790 |
| 116 | response to host immune response (GO:0052572) | 2.69031790 |
| 117 | regulation of antigen processing and presentation (GO:0002577) | 2.69004599 |
| 118 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.68567401 |
| 119 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.68567401 |
| 120 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.68377230 |
| 121 | response to protozoan (GO:0001562) | 2.68246385 |
| 122 | activated T cell proliferation (GO:0050798) | 2.68089802 |
| 123 | mature B cell differentiation (GO:0002335) | 2.67902675 |
| 124 | microglial cell activation (GO:0001774) | 2.65925385 |
| 125 | membrane disassembly (GO:0030397) | 2.65499675 |
| 126 | nuclear envelope disassembly (GO:0051081) | 2.65499675 |
| 127 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.63762187 |
| 128 | mismatch repair (GO:0006298) | 2.63270060 |
| 129 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.62399392 |
| 130 | hepatocyte apoptotic process (GO:0097284) | 2.62349130 |
| 131 | dendritic cell migration (GO:0036336) | 2.61695983 |
| 132 | regulation of tolerance induction (GO:0002643) | 2.61384134 |
| 133 | response to host defenses (GO:0052200) | 2.61366896 |
| 134 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.61366896 |
| 135 | response to host (GO:0075136) | 2.61366896 |
| 136 | DNA conformation change (GO:0071103) | 2.61054146 |
| 137 | translational elongation (GO:0006414) | 2.60905161 |
| 138 | pore complex assembly (GO:0046931) | 2.60426281 |
| 139 | response to muramyl dipeptide (GO:0032495) | 2.58281978 |
| 140 | DNA synthesis involved in DNA repair (GO:0000731) | 2.58090657 |
| 141 | chromatin assembly or disassembly (GO:0006333) | 2.57991244 |
| 142 | establishment of chromosome localization (GO:0051303) | 2.57617534 |
| 143 | ribosomal small subunit biogenesis (GO:0042274) | 2.57414044 |
| 144 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.56863140 |
| 145 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.56855148 |
| 146 | NIK/NF-kappaB signaling (GO:0038061) | 2.56733270 |
| 147 | regulation of T cell tolerance induction (GO:0002664) | 2.55545890 |
| 148 | neutrophil mediated immunity (GO:0002446) | 2.55237325 |
| 149 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.54453473 |
| 150 | positive regulation of isotype switching (GO:0045830) | 2.54316546 |
| 151 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.54234636 |
| 152 | cotranslational protein targeting to membrane (GO:0006613) | 2.53838276 |
| 153 | protein targeting to ER (GO:0045047) | 2.53745731 |
| 154 | regulation of protein heterodimerization activity (GO:0043497) | 2.53261821 |
| 155 | positive regulation of interferon-beta production (GO:0032728) | 2.52764576 |
| 156 | positive regulation of antigen processing and presentation (GO:0002579) | 2.52227402 |
| 157 | neutrophil activation (GO:0042119) | 2.51053463 |
| 158 | mast cell activation (GO:0045576) | 2.50755825 |
| 159 | maturation of SSU-rRNA (GO:0030490) | 2.50298422 |
| 160 | T cell homeostasis (GO:0043029) | 2.49236914 |
| 161 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.49017874 |
| 162 | kinetochore assembly (GO:0051382) | 2.48502868 |
| 163 | B cell proliferation (GO:0042100) | 2.48257202 |
| 164 | interferon-gamma production (GO:0032609) | 2.47325791 |
| 165 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.47067088 |
| 166 | dendritic cell chemotaxis (GO:0002407) | 2.46382121 |
| 167 | cellular extravasation (GO:0045123) | 2.46330915 |
| 168 | negative regulation of RNA splicing (GO:0033119) | 2.46048591 |
| 169 | T cell lineage commitment (GO:0002360) | 2.45043187 |
| 170 | actin nucleation (GO:0045010) | 2.43229373 |
| 171 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.42250511 |
| 172 | angiogenesis involved in wound healing (GO:0060055) | 2.42193038 |
| 173 | response to fungus (GO:0009620) | 2.41186931 |
| 174 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.40635609 |
| 175 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.40278727 |
| 176 | base-excision repair (GO:0006284) | 2.39765634 |
| 177 | negative regulation of B cell proliferation (GO:0030889) | 2.39441042 |
| 178 | regulation of spindle organization (GO:0090224) | 2.39181463 |
| 179 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.37832049 |
| 180 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.37832049 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.10223739 |
| 2 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.74083504 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.16419031 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.90195304 |
| 5 | * FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.74283323 |
| 6 | * IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.68381768 |
| 7 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.52631150 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.51906243 |
| 9 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.50453447 |
| 10 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.41651605 |
| 11 | MYC_22102868_ChIP-Seq_BL_Human | 2.39402267 |
| 12 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.36418489 |
| 13 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.35174403 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.27710592 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.21189655 |
| 16 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.16472176 |
| 17 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.15098630 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.13941746 |
| 19 | * E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.11354426 |
| 20 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.03918790 |
| 21 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 2.02117389 |
| 22 | E2F7_22180533_ChIP-Seq_HELA_Human | 10.7361825 |
| 23 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.95071763 |
| 24 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.92469833 |
| 25 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.87341936 |
| 26 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.81693861 |
| 27 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.79404015 |
| 28 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.75320850 |
| 29 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.71256890 |
| 30 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.70384694 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 1.70131743 |
| 32 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.70055211 |
| 33 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67554529 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66811745 |
| 35 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.66707395 |
| 36 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66699503 |
| 37 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.66667412 |
| 38 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.66213074 |
| 39 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.65590249 |
| 40 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.64957334 |
| 41 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64756966 |
| 42 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.64087403 |
| 43 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.62508696 |
| 44 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.60813430 |
| 45 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.60254219 |
| 46 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.57965221 |
| 47 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.56951683 |
| 48 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.54633377 |
| 49 | MYB_26560356_Chip-Seq_TH1_Human | 1.53887701 |
| 50 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53595493 |
| 51 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.53343800 |
| 52 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.53232871 |
| 53 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.51484075 |
| 54 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.50900060 |
| 55 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.50219544 |
| 56 | * MAF_26560356_Chip-Seq_TH1_Human | 1.49670276 |
| 57 | GATA3_26560356_Chip-Seq_TH2_Human | 1.48235876 |
| 58 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.47863945 |
| 59 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.46960833 |
| 60 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.46835442 |
| 61 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.45721440 |
| 62 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.44606315 |
| 63 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.44486851 |
| 64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.44182715 |
| 65 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.42668329 |
| 66 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.41704081 |
| 67 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.39928038 |
| 68 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.37941497 |
| 69 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.37591471 |
| 70 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.34603077 |
| 71 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.31903788 |
| 72 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.29683948 |
| 73 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.28563811 |
| 74 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.28033885 |
| 75 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.27652373 |
| 76 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.26234330 |
| 77 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.22570163 |
| 78 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.21412485 |
| 79 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.19197459 |
| 80 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.14879797 |
| 81 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.14757330 |
| 82 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13545012 |
| 83 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.13250343 |
| 84 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.11760149 |
| 85 | * FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.11189935 |
| 86 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.10946951 |
| 87 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.10936701 |
| 88 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.10620370 |
| 89 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.10551442 |
| 90 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.10309598 |
| 91 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.09655815 |
| 92 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08712150 |
| 93 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08660144 |
| 94 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.07081372 |
| 95 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.06541482 |
| 96 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.05730781 |
| 97 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.04841808 |
| 98 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03819090 |
| 99 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.03237084 |
| 100 | GATA1_22025678_ChIP-Seq_K562_Human | 1.02589143 |
| 101 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.01544377 |
| 102 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.01028115 |
| 103 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.00216661 |
| 104 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.99440433 |
| 105 | SPI1_23127762_ChIP-Seq_K562_Human | 0.98540129 |
| 106 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 0.98422792 |
| 107 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.97725894 |
| 108 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.97316120 |
| 109 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.95948721 |
| 110 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.95948721 |
| 111 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.94271996 |
| 112 | * MAF_26560356_Chip-Seq_TH2_Human | 0.93861628 |
| 113 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.93292393 |
| 114 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.92249988 |
| 115 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.91001647 |
| 116 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.90904871 |
| 117 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.89766265 |
| 118 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.89311583 |
| 119 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.89281776 |
| 120 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.88629372 |
| 121 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.86454518 |
| 122 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.84175797 |
| 123 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.83721548 |
| 124 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.83193021 |
| 125 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.83085527 |
| 126 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78523698 |
| 127 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.78434763 |
| 128 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77278427 |
| 129 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.75954599 |
| 130 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.75535347 |
| 131 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.75072362 |
| 132 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.74467951 |
| 133 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.72422364 |
| 134 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.71409817 |
| 135 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.71239385 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 3.53884926 |
| 2 | MP0010094_abnormal_chromosome_stability | 3.29100576 |
| 3 | MP0008057_abnormal_DNA_replication | 3.24309489 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.19333976 |
| 5 | MP0003693_abnormal_embryo_hatching | 2.95854722 |
| 6 | MP0003111_abnormal_nucleus_morphology | 2.57420065 |
| 7 | MP0004808_abnormal_hematopoietic_stem | 2.49374384 |
| 8 | MP0003436_decreased_susceptibility_to | 2.48854556 |
| 9 | MP0003077_abnormal_cell_cycle | 2.46617144 |
| 10 | MP0001800_abnormal_humoral_immune | 2.37067764 |
| 11 | MP0003303_peritoneal_inflammation | 2.25229513 |
| 12 | MP0002166_altered_tumor_susceptibility | 2.24914875 |
| 13 | MP0002452_abnormal_antigen_presenting | 2.21082051 |
| 14 | MP0002398_abnormal_bone_marrow | 2.18172871 |
| 15 | MP0000685_abnormal_immune_system | 2.14704457 |
| 16 | MP0010307_abnormal_tumor_latency | 2.09543388 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.09445192 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.08701770 |
| 19 | MP0005671_abnormal_response_to | 2.08488438 |
| 20 | MP0009785_altered_susceptibility_to | 2.07538788 |
| 21 | MP0010352_gastrointestinal_tract_polyps | 2.07111974 |
| 22 | MP0004957_abnormal_blastocyst_morpholog | 2.05832196 |
| 23 | MP0001819_abnormal_immune_cell | 2.05422675 |
| 24 | MP0002419_abnormal_innate_immunity | 2.04647564 |
| 25 | MP0003763_abnormal_thymus_physiology | 2.04546212 |
| 26 | MP0005397_hematopoietic_system_phenotyp | 1.98525536 |
| 27 | MP0001545_abnormal_hematopoietic_system | 1.98525536 |
| 28 | MP0005025_abnormal_response_to | 1.96049205 |
| 29 | MP0002723_abnormal_immune_serum | 1.93754868 |
| 30 | MP0001790_abnormal_immune_system | 1.91526822 |
| 31 | MP0005387_immune_system_phenotype | 1.91526822 |
| 32 | MP0005464_abnormal_platelet_physiology | 1.89624226 |
| 33 | MP0000490_abnormal_crypts_of | 1.88394054 |
| 34 | MP0002006_tumorigenesis | 1.87276586 |
| 35 | MP0006054_spinal_hemorrhage | 1.87227471 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.85099840 |
| 37 | MP0008007_abnormal_cellular_replicative | 1.85090625 |
| 38 | MP0000716_abnormal_immune_system | 1.81460180 |
| 39 | MP0003191_abnormal_cellular_cholesterol | 1.80217008 |
| 40 | MP0002148_abnormal_hypersensitivity_rea | 1.79505216 |
| 41 | MP0002722_abnormal_immune_system | 1.77130818 |
| 42 | MP0003300_gastrointestinal_ulcer | 1.74802791 |
| 43 | MP0002429_abnormal_blood_cell | 1.68366595 |
| 44 | MP0008058_abnormal_DNA_repair | 1.66968602 |
| 45 | MP0009333_abnormal_splenocyte_physiolog | 1.64620384 |
| 46 | MP0002405_respiratory_system_inflammati | 1.63270547 |
| 47 | MP0000465_gastrointestinal_hemorrhage | 1.62516311 |
| 48 | MP0005174_abnormal_tail_pigmentation | 1.61081190 |
| 49 | MP0001853_heart_inflammation | 1.57394703 |
| 50 | MP0009278_abnormal_bone_marrow | 1.57062865 |
| 51 | MP0004381_abnormal_hair_follicle | 1.53849506 |
| 52 | MP0000703_abnormal_thymus_morphology | 1.51938062 |
| 53 | MP0005310_abnormal_salivary_gland | 1.46594085 |
| 54 | MP0002019_abnormal_tumor_incidence | 1.46276969 |
| 55 | MP0000858_altered_metastatic_potential | 1.45472889 |
| 56 | MP0000569_abnormal_digit_pigmentation | 1.43903857 |
| 57 | MP0010155_abnormal_intestine_physiology | 1.39881761 |
| 58 | MP0003806_abnormal_nucleotide_metabolis | 1.32377523 |
| 59 | MP0000350_abnormal_cell_proliferation | 1.32194518 |
| 60 | MP0004883_abnormal_blood_vessel | 1.30221090 |
| 61 | MP0001845_abnormal_inflammatory_respons | 1.30147350 |
| 62 | MP0001873_stomach_inflammation | 1.28878696 |
| 63 | MP0003045_fibrosis | 1.26880530 |
| 64 | MP0002877_abnormal_melanocyte_morpholog | 1.23450996 |
| 65 | MP0005076_abnormal_cell_differentiation | 1.22255425 |
| 66 | MP0003448_altered_tumor_morphology | 1.20466262 |
| 67 | MP0001851_eye_inflammation | 1.17154094 |
| 68 | MP0008932_abnormal_embryonic_tissue | 1.16361517 |
| 69 | MP0001533_abnormal_skeleton_physiology | 1.15526499 |
| 70 | MP0002095_abnormal_skin_pigmentation | 1.12863784 |
| 71 | MP0003724_increased_susceptibility_to | 1.11762584 |
| 72 | MP0003566_abnormal_cell_adhesion | 1.11655335 |
| 73 | MP0004947_skin_inflammation | 1.10696594 |
| 74 | MP0000313_abnormal_cell_death | 1.10242883 |
| 75 | MP0005164_abnormal_response_to | 1.10042773 |
| 76 | MP0003950_abnormal_plasma_membrane | 1.08535403 |
| 77 | MP0005023_abnormal_wound_healing | 1.05313652 |
| 78 | MP0002132_abnormal_respiratory_system | 1.03889511 |
| 79 | MP0000015_abnormal_ear_pigmentation | 1.02390755 |
| 80 | MP0001730_embryonic_growth_arrest | 1.02341509 |
| 81 | MP0008877_abnormal_DNA_methylation | 0.99471191 |
| 82 | MP0004264_abnormal_extraembryonic_tissu | 0.99144210 |
| 83 | MP0003172_abnormal_lysosome_physiology | 0.98831415 |
| 84 | MP0002009_preneoplasia | 0.97406627 |
| 85 | MP0008438_abnormal_cutaneous_collagen | 0.95844712 |
| 86 | MP0003656_abnormal_erythrocyte_physiolo | 0.95516110 |
| 87 | MP0000343_altered_response_to | 0.93340126 |
| 88 | MP0008260_abnormal_autophagy | 0.89167251 |
| 89 | MP0002933_joint_inflammation | 0.87668213 |
| 90 | MP0003091_abnormal_cell_migration | 0.87545593 |
| 91 | MP0003786_premature_aging | 0.87118460 |
| 92 | MP0003866_abnormal_defecation | 0.87004304 |
| 93 | MP0000371_diluted_coat_color | 0.84724925 |
| 94 | MP0008469_abnormal_protein_level | 0.84696435 |
| 95 | MP0009764_decreased_sensitivity_to | 0.83586440 |
| 96 | MP0003183_abnormal_peptide_metabolism | 0.82195528 |
| 97 | MP0002998_abnormal_bone_remodeling | 0.80855585 |
| 98 | MP0005075_abnormal_melanosome_morpholog | 0.78768067 |
| 99 | MP0010234_abnormal_vibrissa_follicle | 0.77884437 |
| 100 | MP0002080_prenatal_lethality | 0.72224338 |
| 101 | MP0003567_abnormal_fetal_cardiomyocyte | 0.72169786 |
| 102 | MP0003705_abnormal_hypodermis_morpholog | 0.72151864 |
| 103 | MP0003828_pulmonary_edema | 0.71628046 |
| 104 | MP0005408_hypopigmentation | 0.71257492 |
| 105 | MP0005058_abnormal_lysosome_morphology | 0.71105801 |
| 106 | MP0001663_abnormal_digestive_system | 0.69677929 |
| 107 | MP0003984_embryonic_growth_retardation | 0.69443925 |
| 108 | MP0002086_abnormal_extraembryonic_tissu | 0.69382074 |
| 109 | MP0001697_abnormal_embryo_size | 0.69266004 |
| 110 | MP0002088_abnormal_embryonic_growth/wei | 0.67273028 |
| 111 | MP0001915_intracranial_hemorrhage | 0.67213379 |
| 112 | MP0001672_abnormal_embryogenesis/_devel | 0.66990241 |
| 113 | MP0005380_embryogenesis_phenotype | 0.66990241 |
| 114 | MP0005621_abnormal_cell_physiology | 0.66859479 |
| 115 | MP0003279_aneurysm | 0.64546817 |
| 116 | MP0005166_decreased_susceptibility_to | 0.64188762 |
| 117 | MP0009763_increased_sensitivity_to | 0.63550353 |
| 118 | MP0004197_abnormal_fetal_growth/weight/ | 0.62924447 |
| 119 | MP0003943_abnormal_hepatobiliary_system | 0.62200254 |
| 120 | MP0006082_CNS_inflammation | 0.62132227 |
| 121 | MP0000249_abnormal_blood_vessel | 0.62031425 |
| 122 | MP0001243_abnormal_dermal_layer | 0.61641808 |
| 123 | MP0009765_abnormal_xenobiotic_induced | 0.61140819 |
| 124 | MP0002136_abnormal_kidney_physiology | 0.60522137 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.55041206 |
| 2 | Thrombocytosis (HP:0001894) | 4.09143291 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 3.96746049 |
| 4 | IgM deficiency (HP:0002850) | 3.87413307 |
| 5 | Eczematoid dermatitis (HP:0000976) | 3.69603890 |
| 6 | Cellulitis (HP:0100658) | 3.61029192 |
| 7 | Recurrent viral infections (HP:0004429) | 3.53825755 |
| 8 | Autoimmune hemolytic anemia (HP:0001890) | 3.48915591 |
| 9 | Chromsome breakage (HP:0040012) | 3.40060696 |
| 10 | Reticulocytopenia (HP:0001896) | 3.33506476 |
| 11 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.22695684 |
| 12 | Optic neuritis (HP:0100653) | 3.16649848 |
| 13 | Retrobulbar optic neuritis (HP:0100654) | 3.16649848 |
| 14 | Myositis (HP:0100614) | 3.03279070 |
| 15 | Chronic otitis media (HP:0000389) | 3.01931016 |
| 16 | Agnosia (HP:0010524) | 2.98768322 |
| 17 | Gastrointestinal infarctions (HP:0005244) | 2.96242477 |
| 18 | Encephalitis (HP:0002383) | 2.95496485 |
| 19 | Chronic obstructive pulmonary disease (HP:0006510) | 2.95289197 |
| 20 | Obstructive lung disease (HP:0006536) | 2.95289197 |
| 21 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.93209549 |
| 22 | Recurrent bronchitis (HP:0002837) | 2.93160847 |
| 23 | Recurrent fungal infections (HP:0002841) | 2.92504752 |
| 24 | Pulmonary infiltrates (HP:0002113) | 2.92098420 |
| 25 | Petechiae (HP:0000967) | 2.90329644 |
| 26 | Abnormality of chromosome stability (HP:0003220) | 2.88624175 |
| 27 | Meningitis (HP:0001287) | 2.88358303 |
| 28 | Colitis (HP:0002583) | 2.88064429 |
| 29 | Mediastinal lymphadenopathy (HP:0100721) | 2.86984503 |
| 30 | Stomatitis (HP:0010280) | 2.85045659 |
| 31 | Birth length less than 3rd percentile (HP:0003561) | 2.76873434 |
| 32 | Chronic diarrhea (HP:0002028) | 2.74663679 |
| 33 | Abnormal platelet volume (HP:0011876) | 2.67920055 |
| 34 | Abnormality of T cell physiology (HP:0011840) | 2.65086465 |
| 35 | Arterial thrombosis (HP:0004420) | 2.63485663 |
| 36 | Viral hepatitis (HP:0006562) | 2.63452614 |
| 37 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.62859753 |
| 38 | Abnormal number of erythroid precursors (HP:0012131) | 2.61201473 |
| 39 | Abnormality of the prostate (HP:0008775) | 2.61180795 |
| 40 | Abnormality of T cells (HP:0002843) | 2.61036688 |
| 41 | Cutaneous melanoma (HP:0012056) | 2.60803205 |
| 42 | Lymphoma (HP:0002665) | 2.60312201 |
| 43 | Aplastic anemia (HP:0001915) | 2.58293461 |
| 44 | Agammaglobulinemia (HP:0004432) | 2.56936853 |
| 45 | Myelodysplasia (HP:0002863) | 2.55988858 |
| 46 | Recurrent skin infections (HP:0001581) | 2.55957599 |
| 47 | Osteomyelitis (HP:0002754) | 2.55021055 |
| 48 | Severe combined immunodeficiency (HP:0004430) | 2.52209631 |
| 49 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.51575007 |
| 50 | Spontaneous hematomas (HP:0007420) | 2.50035402 |
| 51 | Lymphopenia (HP:0001888) | 2.49521968 |
| 52 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.47044590 |
| 53 | Combined immunodeficiency (HP:0005387) | 2.46334720 |
| 54 | Keratoconjunctivitis sicca (HP:0001097) | 2.44958651 |
| 55 | Hemoptysis (HP:0002105) | 2.42483417 |
| 56 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.42035857 |
| 57 | Abnormality of B cell number (HP:0010975) | 2.41101174 |
| 58 | B lymphocytopenia (HP:0010976) | 2.41101174 |
| 59 | Volvulus (HP:0002580) | 2.40490906 |
| 60 | Prolonged bleeding time (HP:0003010) | 2.40228089 |
| 61 | Prostate neoplasm (HP:0100787) | 2.39711797 |
| 62 | Increased IgE level (HP:0003212) | 2.33394563 |
| 63 | Syringomyelia (HP:0003396) | 2.33300962 |
| 64 | Spinal cord lesions (HP:0100561) | 2.33300962 |
| 65 | T lymphocytopenia (HP:0005403) | 2.32725635 |
| 66 | Acute myeloid leukemia (HP:0004808) | 2.30017299 |
| 67 | Abnormality of eosinophils (HP:0001879) | 2.29613094 |
| 68 | Hypoplasia of the thymus (HP:0000778) | 2.27165647 |
| 69 | Recurrent sinusitis (HP:0011108) | 2.25277095 |
| 70 | Increased mean platelet volume (HP:0011877) | 2.24289071 |
| 71 | Keratoconjunctivitis (HP:0001096) | 2.23762257 |
| 72 | Increased IgM level (HP:0003496) | 2.22569258 |
| 73 | Amaurosis fugax (HP:0100576) | 2.22242554 |
| 74 | Recurrent pneumonia (HP:0006532) | 2.21538606 |
| 75 | Abnormality of T cell number (HP:0011839) | 2.21081992 |
| 76 | Periodontitis (HP:0000704) | 2.20803235 |
| 77 | Increased density of long bones (HP:0006392) | 2.20782944 |
| 78 | Vasculitis (HP:0002633) | 2.20582064 |
| 79 | Panhypogammaglobulinemia (HP:0003139) | 2.20465115 |
| 80 | IgA deficiency (HP:0002720) | 2.18488946 |
| 81 | Recurrent lower respiratory tract infections (HP:0002783) | 2.17095599 |
| 82 | Abnormality of macrophages (HP:0004311) | 2.16739058 |
| 83 | Abnormality of the fingertips (HP:0001211) | 2.16176040 |
| 84 | Entropion (HP:0000621) | 2.12432953 |
| 85 | Poikiloderma (HP:0001029) | 2.11885349 |
| 86 | Osteolytic defects of the hand bones (HP:0009699) | 2.11773972 |
| 87 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.11773972 |
| 88 | Clubbing of toes (HP:0100760) | 2.11042225 |
| 89 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.10231374 |
| 90 | Recurrent cutaneous fungal infections (HP:0011370) | 2.10231374 |
| 91 | Inflammation of the large intestine (HP:0002037) | 2.09736035 |
| 92 | Gastrointestinal inflammation (HP:0004386) | 2.09613537 |
| 93 | Verrucae (HP:0200043) | 2.09085417 |
| 94 | Papilloma (HP:0012740) | 2.09085417 |
| 95 | Fatigue (HP:0012378) | 2.08916019 |
| 96 | Acute hepatic failure (HP:0006554) | 2.08832389 |
| 97 | Abnormality of the preputium (HP:0100587) | 2.07822941 |
| 98 | IgG deficiency (HP:0004315) | 2.06908697 |
| 99 | Thyroiditis (HP:0100646) | 2.05769702 |
| 100 | Albinism (HP:0001022) | 2.05543255 |
| 101 | Bone marrow hypocellularity (HP:0005528) | 2.04285678 |
| 102 | Bronchitis (HP:0012387) | 2.03673750 |
| 103 | Gastrointestinal stroma tumor (HP:0100723) | 2.03672057 |
| 104 | Hematochezia (HP:0002573) | 2.03375398 |
| 105 | Leukopenia (HP:0001882) | 2.01884917 |
| 106 | Granulocytopenia (HP:0001913) | 2.01872299 |
| 107 | Eosinophilia (HP:0001880) | 2.01871136 |
| 108 | 11 pairs of ribs (HP:0000878) | 2.01679940 |
| 109 | Epistaxis (HP:0000421) | 2.01000717 |
| 110 | Basal cell carcinoma (HP:0002671) | 1.99738944 |
| 111 | Skin ulcer (HP:0200042) | 1.98610666 |
| 112 | Subacute progressive viral hepatitis (HP:0006572) | 1.98598703 |
| 113 | Impaired platelet aggregation (HP:0003540) | 1.97403233 |
| 114 | Abnormal platelet function (HP:0011869) | 1.97403233 |
| 115 | Urticaria (HP:0001025) | 1.97391424 |
| 116 | Autoimmune thrombocytopenia (HP:0001973) | 1.96967657 |
| 117 | Pallor (HP:0000980) | 1.96109522 |
| 118 | Chest pain (HP:0100749) | 1.95925313 |
| 119 | Meckel diverticulum (HP:0002245) | 1.95649339 |
| 120 | Abnormality of the pleura (HP:0002103) | 1.95196014 |
| 121 | Prominent nose (HP:0000448) | 1.94444088 |
| 122 | Hypergammaglobulinemia (HP:0010702) | 1.93508942 |
| 123 | Gingivitis (HP:0000230) | 1.92586494 |
| 124 | Leukocytosis (HP:0001974) | 1.91541571 |
| 125 | Absent frontal sinuses (HP:0002688) | 1.91096077 |
| 126 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.90067349 |
| 127 | Pulmonary embolism (HP:0002204) | 1.89807501 |
| 128 | Pustule (HP:0200039) | 1.89031336 |
| 129 | Pulmonary fibrosis (HP:0002206) | 1.86547300 |
| 130 | Abnormality of the ileum (HP:0001549) | 1.86491008 |
| 131 | Increased nuchal translucency (HP:0010880) | 1.85903853 |
| 132 | Chronic sinusitis (HP:0011109) | 1.85304565 |
| 133 | Orchitis (HP:0100796) | 1.83972865 |
| 134 | Sepsis (HP:0100806) | 1.81826429 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | CDC7 | 3.63463473 |
| 2 | MAP4K1 | 3.31973054 |
| 3 | IRAK4 | 2.30838493 |
| 4 | WEE1 | 2.30084682 |
| 5 | PRPF4B | 2.29962263 |
| 6 | NME2 | 2.20031762 |
| 7 | KIT | 2.15620183 |
| 8 | STK10 | 2.15226467 |
| 9 | NEK2 | 2.10146905 |
| 10 | MARK3 | 2.08513381 |
| 11 | BTK | 1.97324899 |
| 12 | EEF2K | 1.96223300 |
| 13 | EIF2AK1 | 1.94158172 |
| 14 | BMPR2 | 1.88506667 |
| 15 | TEC | 1.83765755 |
| 16 | ACVR1B | 1.73348926 |
| 17 | SIK3 | 1.68816035 |
| 18 | BLK | 1.66354390 |
| 19 | BRSK2 | 1.63028925 |
| 20 | MAP2K3 | 1.62210359 |
| 21 | CSF1R | 1.62168231 |
| 22 | SCYL2 | 1.61409747 |
| 23 | NLK | 1.59907260 |
| 24 | ATR | 1.58025592 |
| 25 | LRRK2 | 1.55608868 |
| 26 | TYK2 | 1.52314934 |
| 27 | RPS6KA4 | 1.50883516 |
| 28 | MAP3K13 | 1.49994791 |
| 29 | STK4 | 1.49731697 |
| 30 | CLK1 | 1.48547820 |
| 31 | CDK4 | 1.42744078 |
| 32 | FRK | 1.41617530 |
| 33 | MELK | 1.39226103 |
| 34 | PIM1 | 1.37832367 |
| 35 | PKN2 | 1.37222813 |
| 36 | MAP3K14 | 1.33569174 |
| 37 | SYK | 1.32299297 |
| 38 | MST1R | 1.31556550 |
| 39 | EIF2AK3 | 1.29785034 |
| 40 | GRK6 | 1.29731723 |
| 41 | ZAP70 | 1.29312356 |
| 42 | TRPM7 | 1.28570412 |
| 43 | SRPK1 | 1.26648444 |
| 44 | ERN1 | 1.25151669 |
| 45 | TGFBR1 | 1.22805230 |
| 46 | JAK3 | 1.21953381 |
| 47 | AURKB | 1.21411763 |
| 48 | TXK | 1.20883793 |
| 49 | MST4 | 1.20711421 |
| 50 | NEK1 | 1.20094608 |
| 51 | BUB1 | 1.19383474 |
| 52 | MAP3K8 | 1.19018032 |
| 53 | TLK1 | 1.17175324 |
| 54 | PIM2 | 1.17169819 |
| 55 | FLT3 | 1.17091140 |
| 56 | CDK6 | 1.16641000 |
| 57 | CDK7 | 1.16515331 |
| 58 | PASK | 1.16308295 |
| 59 | VRK1 | 1.15349883 |
| 60 | MAP3K10 | 1.11348111 |
| 61 | TESK2 | 1.10437471 |
| 62 | MAP3K3 | 1.07916708 |
| 63 | MKNK1 | 1.07636786 |
| 64 | RPS6KB2 | 1.06833708 |
| 65 | SMG1 | 1.05410592 |
| 66 | ITK | 1.03949131 |
| 67 | NEK9 | 1.02705375 |
| 68 | TTN | 1.01904078 |
| 69 | JAK2 | 1.01114696 |
| 70 | LYN | 1.00811703 |
| 71 | TAF1 | 0.98260368 |
| 72 | TBK1 | 0.98211644 |
| 73 | CDK12 | 0.97184242 |
| 74 | PLK1 | 0.93375664 |
| 75 | MAP2K6 | 0.92116705 |
| 76 | HCK | 0.91314876 |
| 77 | FGFR4 | 0.90761455 |
| 78 | TGFBR2 | 0.90256508 |
| 79 | TTK | 0.89971494 |
| 80 | PIK3CG | 0.89832820 |
| 81 | MUSK | 0.88473530 |
| 82 | FGR | 0.87555469 |
| 83 | FES | 0.87218484 |
| 84 | LCK | 0.85872806 |
| 85 | STK16 | 0.84099603 |
| 86 | BRSK1 | 0.82563510 |
| 87 | CHEK2 | 0.80922367 |
| 88 | CDK8 | 0.79826895 |
| 89 | CSK | 0.79501443 |
| 90 | IKBKB | 0.77731634 |
| 91 | PAK4 | 0.77707372 |
| 92 | CCNB1 | 0.76081433 |
| 93 | IKBKE | 0.75599872 |
| 94 | ZAK | 0.74353276 |
| 95 | TSSK6 | 0.73878213 |
| 96 | PLK4 | 0.71926008 |
| 97 | HIPK2 | 0.70633031 |
| 98 | YES1 | 0.70511766 |
| 99 | JAK1 | 0.69808282 |
| 100 | CHEK1 | 0.69531505 |
| 101 | BRD4 | 0.68078549 |
| 102 | EIF2AK2 | 0.66142572 |
| 103 | DYRK3 | 0.65506706 |
| 104 | TAOK3 | 0.64925824 |
| 105 | MATK | 0.64174974 |
| 106 | RIPK4 | 0.64007310 |
| 107 | PRKCH | 0.63991725 |
| 108 | TAOK2 | 0.60759129 |
| 109 | PLK3 | 0.60107662 |
| 110 | MKNK2 | 0.59536501 |
| 111 | ATM | 0.59447749 |
| 112 | NUAK1 | 0.59123130 |
| 113 | PRKCQ | 0.58981473 |
| 114 | PRKD2 | 0.58814249 |
| 115 | IRAK3 | 0.56924842 |
| 116 | KDR | 0.55182241 |
| 117 | CDC42BPA | 0.55003314 |
| 118 | ERBB3 | 0.54877906 |
| 119 | TRIB3 | 0.53092474 |
| 120 | RPS6KA6 | 0.52543222 |
| 121 | FGFR3 | 0.51809745 |
| 122 | RPS6KL1 | 0.49883930 |
| 123 | RPS6KC1 | 0.49883930 |
| 124 | FER | 0.49741896 |
| 125 | TESK1 | 0.49392540 |
| 126 | ALK | 0.48058443 |
| 127 | CDK9 | 0.47933007 |
| 128 | AKT3 | 0.47602296 |
| 129 | IRAK1 | 0.47136743 |
| 130 | EPHB1 | 0.46694810 |
| 131 | MAPK11 | 0.46304066 |
| 132 | CDK2 | 0.45449890 |
| 133 | CHUK | 0.42582701 |
| 134 | MAPK7 | 0.41225847 |
| 135 | MAPKAPK2 | 0.40099901 |
| 136 | TNK2 | 0.39503319 |
| 137 | ABL1 | 0.38432543 |
| 138 | MAPK4 | 0.36516271 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 5.06411406 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.86678033 |
| 3 | Base excision repair_Homo sapiens_hsa03410 | 2.80678986 |
| 4 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.61166499 |
| 5 | Homologous recombination_Homo sapiens_hsa03440 | 2.59606487 |
| 6 | Cell cycle_Homo sapiens_hsa04110 | 2.35389940 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 2.24089637 |
| 8 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.16109354 |
| 9 | Non-homologous end-joining_Homo sapiens_hsa03450 | 2.06635990 |
| 10 | Spliceosome_Homo sapiens_hsa03040 | 2.03274510 |
| 11 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.00509163 |
| 12 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.91286924 |
| 13 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.85906878 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.85670067 |
| 15 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.83724435 |
| 16 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.80526375 |
| 17 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.78583618 |
| 18 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.70851568 |
| 19 | RNA transport_Homo sapiens_hsa03013 | 1.64364123 |
| 20 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.53609427 |
| 21 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.53432330 |
| 22 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.53116501 |
| 23 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52396158 |
| 24 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.46882661 |
| 25 | Measles_Homo sapiens_hsa05162 | 1.46001089 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.43565909 |
| 27 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.35956959 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.30701730 |
| 29 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.30334428 |
| 30 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.28331455 |
| 31 | Legionellosis_Homo sapiens_hsa05134 | 1.26316148 |
| 32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.22782416 |
| 33 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.21193779 |
| 34 | Proteasome_Homo sapiens_hsa03050 | 1.19953392 |
| 35 | Shigellosis_Homo sapiens_hsa05131 | 1.19182636 |
| 36 | RNA degradation_Homo sapiens_hsa03018 | 1.18668111 |
| 37 | Hepatitis B_Homo sapiens_hsa05161 | 1.18009217 |
| 38 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.13469961 |
| 39 | Apoptosis_Homo sapiens_hsa04210 | 1.12599634 |
| 40 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.12576705 |
| 41 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.11402752 |
| 42 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.10076357 |
| 43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.05977231 |
| 44 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.05658842 |
| 45 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.04032743 |
| 46 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.03319903 |
| 47 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.02719992 |
| 48 | Pertussis_Homo sapiens_hsa05133 | 1.01673112 |
| 49 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00465136 |
| 50 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.00407270 |
| 51 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.00089446 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.98019536 |
| 53 | RNA polymerase_Homo sapiens_hsa03020 | 0.96602319 |
| 54 | Influenza A_Homo sapiens_hsa05164 | 0.93699635 |
| 55 | Platelet activation_Homo sapiens_hsa04611 | 0.93276417 |
| 56 | HTLV-I infection_Homo sapiens_hsa05166 | 0.92058249 |
| 57 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.91522691 |
| 58 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.91428336 |
| 59 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.90869969 |
| 60 | Tuberculosis_Homo sapiens_hsa05152 | 0.90213026 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88161143 |
| 62 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.87796742 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.84584042 |
| 64 | Other glycan degradation_Homo sapiens_hsa00511 | 0.82524965 |
| 65 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81830580 |
| 66 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.80709144 |
| 67 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.80606963 |
| 68 | Malaria_Homo sapiens_hsa05144 | 0.77931310 |
| 69 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.77823273 |
| 70 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.77117043 |
| 71 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.74255222 |
| 72 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.71138605 |
| 73 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.69659694 |
| 74 | Salmonella infection_Homo sapiens_hsa05132 | 0.69327961 |
| 75 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.69276189 |
| 76 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.68098742 |
| 77 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.66883852 |
| 78 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.64762652 |
| 79 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61885482 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.60182280 |
| 81 | Asthma_Homo sapiens_hsa05310 | 0.59842454 |
| 82 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59505740 |
| 83 | Purine metabolism_Homo sapiens_hsa00230 | 0.57918007 |
| 84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.56657057 |
| 85 | Basal transcription factors_Homo sapiens_hsa03022 | 0.56647017 |
| 86 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.53437954 |
| 87 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.52976986 |
| 88 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51165311 |
| 89 | Endometrial cancer_Homo sapiens_hsa05213 | 0.51019844 |
| 90 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.48709883 |
| 91 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48704634 |
| 92 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.48080002 |
| 93 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47497545 |
| 94 | Phagosome_Homo sapiens_hsa04145 | 0.47368683 |
| 95 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.47349490 |
| 96 | Allograft rejection_Homo sapiens_hsa05330 | 0.45881493 |
| 97 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.45489161 |
| 98 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.45119443 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.43039710 |
| 100 | Alcoholism_Homo sapiens_hsa05034 | 0.42355508 |
| 101 | Thyroid cancer_Homo sapiens_hsa05216 | 0.41852744 |
| 102 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.41359779 |
| 103 | Hepatitis C_Homo sapiens_hsa05160 | 0.40511715 |
| 104 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.39077259 |
| 105 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.38980253 |
| 106 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38269197 |
| 107 | Protein export_Homo sapiens_hsa03060 | 0.35729802 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35686778 |
| 109 | Prostate cancer_Homo sapiens_hsa05215 | 0.35514252 |
| 110 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.35461665 |
| 111 | Lysosome_Homo sapiens_hsa04142 | 0.35347486 |
| 112 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.34883468 |
| 113 | Lysine degradation_Homo sapiens_hsa00310 | 0.34788098 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.33742246 |
| 115 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.32905130 |
| 116 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.31815757 |
| 117 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.31293473 |
| 118 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31287892 |
| 119 | Pathways in cancer_Homo sapiens_hsa05200 | 0.30146751 |
| 120 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.29010887 |
| 121 | Bladder cancer_Homo sapiens_hsa05219 | 0.28033140 |
| 122 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.27639637 |
| 123 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.26957699 |
| 124 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.26788033 |

